Abvitro
AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes.
Business Model:
Revenue: $10M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Abvitro Information
Abvitro was acquired by
Juno Therapeutics.
The acquisition happend on 2016-01-11.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 307 Westlake Ave N
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
series a
Raised Last:
$2M
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
AbVitro is an immuno-oncology antibody discovery platform that allows for the discovery of cancer specific tumor infiltrating lymphocytes.
Contact Phone:
+12065821600
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2012 | Series A | 1 | $1.9M |
Sante Ventures Sante Ventures |
3/2012 | Equity | $1.9M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
